Mission

ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value.  Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.

Staff Only

Remember Me
TwitterLinkedinFacebookFeed
ICER at the HTAi Annual Meeting

ICER's President, Steve Pearson, participated in the panels "Closing the Loop: HTA, Evidence Gaps, and Recommendations for New Research" and "HTA and Priority Setting: International Comparisons" and ICER's Chief Review Officer, Dan Ollendorf, presented "Formatting Cost-Effectiveness Findings for Multiple Stakeholders: The Comparative Value Evidence Table" at the HTAi Annual Meeting in Dublin, Ireland, June 5-8, 2010.